THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation...
Year: 2020
XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail
Candidate Therapy for Flu+Covid-19 Co-infection Shows Potent Anti-Viral Potential AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
RenovaCare Intellectual Property Update RenovaCare Awarded New Patents for SkinGun™: Ultra-Gentle Cell Spray Technology ROSELAND, N.J., Nov. 19, 2020 (GLOBE...
Aditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT)
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity Mountain View, CA , Nov. 19,...
Ambu A/S: Capital increase in connection with exercise of warrants issued
Capital increase in connection with exercise of warrants Ambu A/S issued 770,000 warrants in 2015, and 419,500 warrants in November...
Outlook Therapeutics Announces Creation of Global Retina Advisory Council
Advisory Council to collaborate on outreach to retinal clinicians to support development and commercialization of ONS-5010, an investigational ophthalmic formulation...
Rezolute to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
REDWOOD CITY, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq:RZLT), a clinical stage biopharmaceutical company dedicated to advancing...
Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
CAMBRIDGE, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference
BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma
Investigational drug RNL™ delivers up to fifteen times the absorbed dose of radiation compared to standard external beam radiation therapy...
Beyond Air® to Participate in the 32nd Annual Piper Sandler Healthcare Conference from December 1-3, 2020
GARDEN CITY, N.Y., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
BeyondSpring Announces Pricing of Ordinary Shares
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company...
Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the...
Tabula Rasa HealthCare Partners with Heritage Health Solutions to Expand Enhanced Medication Therapy Management Services to Self-insured Employers
MOORESTOWN, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the...
DLH to Participate in the Upcoming Truist Industrials & Services Conference
ATLANTA, Nov. 19, 2020 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
AskBio and Selecta Biosciences Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia
Gene therapy MMA-101 has obtained both orphan drug designation and rare pediatric disease designation from the FDA RESEARCH TRIANGLE PARK,...
Predictmedix and Paras Defence & Space Technologies Are Joining Forces to Launch Predictmedix’s Proprietary Technologies in the Government and Public Sectors
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce that...
Aprea Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
BOSTON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel...
AskBio and Selecta Biosciences Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia
Gene therapy MMA-101 has obtained both orphan drug designation and rare pediatric disease designation from the FDA RESEARCH TRIANGLE PARK,...
Sio Gene Therapies Appoints Gene Therapy Pioneer Guangping Gao, Ph.D., as Chief AAV Scientific Advisor
A pioneering researcher, Dr. Gao has made foundational contributions to the discovery of novel AAV vectors for gene therapy Dr....